Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial

Watchlist | Portfolio | Dashboard

Faster, Cleaner, Better.

Mgc Pharmaceuticals Limited (MXC.LN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Stock Comparison for [[ item.sessionDateDisplayLong ]]

Results

Want to compare other data? Select Fields

Symbol	MXC.LN
Company	Mgc Pharmaceuticals Limited
Price Information
Exchange	LSE
Open	22.000
High	22.000
Low	22.000
Latest	22.000
Change	unch
% Change	unch
Volume	N/A
20-Day Average Volume	30,452
Previous Close	22.000
Industry	N/A
Has Options	No
Technicals
20-Day Moving Average	21.145
20-Day Raw Stochastic	60.00%
20-Day Relative Strength	51.84
Weighted Alpha	-84.47
Today's Opinion	40% Sell
Previous Opinion	40% Sell
Last Month's Opinion	100% Sell
Performance
5-Days
%Chg	+4.76% since 03/25/24
Low	20.000 on 03/28/24
High	24.000 on 03/28/24
1-Month
%Chg	+15.79% since 03/01/24
Low	19.000 on 03/14/24
High	24.000 on 03/28/24
3-Month
%Chg	-15.38% since 01/03/24
Low	17.000 on 02/01/24
High	26.300 on 01/05/24
6-Month
%Chg	-71.79% since 10/03/23
Low	13.100 on 11/02/23
High	90.000 on 10/24/23
Key Statistics
Market Capitalization, $K	10,471
Shares Outstanding, K	43,852
Annual Sales	3,387,567
Annual Net Income	-20,823,583
Last Quarter Sales	N/A
Last Quarter Net Income	N/A
60-Month Beta	N/A
Per-Share Information
Most Recent Earnings	N/A
Latest Earnings Date	N/A
Most Recent Dividend	N/A
Next Ex-Dividends Date	N/A
Ratios
Price/Earnings ttm	N/A